Patents by Inventor Daniel Gage

Daniel Gage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FACTOR VIII POLYPEPTIDE FORMULATIONS
    Publication number: 20210069300
    Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
    Type: Application
    Filed: August 14, 2020
    Publication date: March 11, 2021
    Inventors: Kevin MALONEY, Daniel GAGE, Ahmad ABDUL-FATTAH
  • Factor VIII polypeptide formulations
    Patent number: 10786554
    Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: September 29, 2020
    Assignee: Bioverativ Therapeutics Inc.
    Inventors: Kevin Maloney, Daniel Gage, Ahmad Abdul-Fattah
  • Pallet-less brick
    Patent number: 10486873
    Abstract: A pallet-less brick is provided that allows for materials to be transported without the use of straps or pallets, which makes the transportation and subsequent use of the materials more efficient and more environmentally friendly. The pallet-less brick can have a generally planar body with a series of protrusions and recesses extending in different directions. A protrusion extending in one direction can be received in a recess of an adjacent brick, such that the bricks are stackable without the use of straps or pallets. Similarly, a second protrusion and recess combination fulfill a similar function, and the multiple protrusions and recesses secure stacked pallets in at least two directions.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: November 26, 2019
    Assignee: BALL CORPORATION
    Inventor: Daniel Gage
  • PALLET-LESS BRICK
    Publication number: 20180244449
    Abstract: A pallet-less brick is provided that allows for materials to be transported without the use of straps or pallets, which makes the transportation and subsequent use of the materials more efficient and more environmentally friendly. The pallet-less brick can have a generally planar body with a series of protrusions and recesses extending in different directions. A protrusion extending in one direction can be received in a recess of an adjacent brick, such that the bricks are stackable without the use of straps or pallets. Similarly, a second protrusion and recess combination fulfill a similar function, and the multiple protrusions and recesses secure stacked pallets in at least two directions.
    Type: Application
    Filed: February 27, 2018
    Publication date: August 30, 2018
    Inventor: Daniel Gage
  • FACTOR VIII POLYPEPTIDE FORMULATIONS
    Publication number: 20170281734
    Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
    Type: Application
    Filed: March 9, 2017
    Publication date: October 5, 2017
    Applicant: Bioverativ Therapeutics Inc.
    Inventors: Kevin MALONEY, Daniel Gage, Ahmad Abdul-Fattah
  • Factor VIII polypeptide formulations
    Patent number: 9623088
    Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: April 18, 2017
    Assignee: Bioverativ Therapeutics Inc.
    Inventors: Kevin Maloney, Daniel Gage, Ahmad Abdul-Fattah
  • Factor VIII Polypeptide Formulations
    Publication number: 20140308280
    Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 16, 2014
    Applicant: Biogen Idec MA Inc.
    Inventors: Kevin MALONEY, Daniel Gage, Ahmad Abdul-Fattah